Cogent Biosciences, Inc.COGTNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P11
Within normal range
vs 5Y Ago
-2.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -24.19% |
| Q3 2025 | -17.70% |
| Q2 2025 | 18.47% |
| Q1 2025 | -10.56% |
| Q4 2024 | -16.05% |
| Q3 2024 | -21.97% |
| Q2 2024 | 18.54% |
| Q1 2024 | -18.51% |
| Q4 2023 | -16.52% |
| Q3 2023 | -14.31% |
| Q2 2023 | 17.96% |
| Q1 2023 | -29.47% |
| Q4 2022 | 16.89% |
| Q3 2022 | -36.78% |
| Q2 2022 | 4.08% |
| Q1 2022 | -35.67% |
| Q4 2021 | -38.88% |
| Q3 2021 | -20.88% |
| Q2 2021 | -11.16% |
| Q1 2021 | -21.35% |
| Q4 2020 | 8.78% |
| Q3 2020 | -23.34% |
| Q2 2020 | -5.46% |
| Q1 2020 | 6.68% |
| Q4 2019 | 16.96% |
| Q3 2019 | 10.22% |
| Q2 2019 | 1.87% |
| Q1 2019 | -23.20% |
| Q4 2018 | -22.48% |
| Q3 2018 | 7.71% |
| Q2 2018 | -3.04% |
| Q1 2018 | -21.77% |
| Q4 2017 | -0.78% |
| Q3 2017 | -9.82% |
| Q2 2017 | 21.22% |
| Q1 2017 | 0.00% |
| Q3 2016 | 0.00% |
| Q3 2015 | 0.00% |